key: cord-0935176-kh55r424 authors: Xue, Guohui; Gan, Xing; Wu, Zhiqiang; Xie, Dan; Xiong, Yan; Hua, Lin; Zhou, Bing; Zhou, Nanjin; Xiang, Jie; Li, Junming title: Novel Serological Biomarkers for Inflammation in Predicting Disease Severity in Patients with COVID-19 date: 2020-10-03 journal: Int Immunopharmacol DOI: 10.1016/j.intimp.2020.107065 sha: be690f3a7ba31ffecc6d9b84bda9be93542cda00 doc_id: 935176 cord_uid: kh55r424 BACKGROUND: Patients with severe coronavirus disease 2019 (COVID-19) develop acute respiratory distress and multi-system organ failure and are associated with poor prognosis and high mortality. Thus, there is an urgent need to identify early diagnostic and prognostic biomarkers to determine the risk of developing serious illness. METHODS: We retrospectively analyzed 114 patients with COVID-19 at the Jinyintan Hospital, Wuhan based on their clinical and laboratory data. Patients were categorized into severe and mild to moderate disease groups. We analyzed the potential of serological inflammation indicators in predicting the severity of COVID-19 in patients using univariate and multivariate logistic regression, receiver operating characteristic curves, and nomogram analysis. The Spearman method was used to understand the correlation between the serological biomarkers and duration of hospital stay. RESULTS: Patients with severe disease had reduced neutrophils and lymphocytes; severe coagulation dysfunction; altered content of biochemical factors (such as urea, lactate dehydrogenase); elevated high sensitivity C-reactive protein levels, neutrophil-lymphocyte, platelet-lymphocyte, and derived neutrophil-lymphocyte ratios, high sensitivity C-reactive protein-prealbumin ratio (HsCPAR), systemic immune-inflammation index, and high sensitivity C-reactive protein-albumin ratio (HsCAR); and low lymphocyte-monocyte ratio, prognostic nutritional index (PNI), and albumin-to-fibrinogen ratio. PNI, HsCAR, and HsCPAR correlated with the risk of severe disease. The nomogram combining the three parameters showed good discrimination with a C-index of 0.873 and reliable calibration. Moreover, HsCAR and HsCPAR correlated with duration of hospital stay. CONCLUSION: Taken together, PNI, HsCAR, and HsCPAR may serve as accurate biomarkers for the prediction of disease severity in patients with COVID-19 upon admission/hospitalization. Coronavirus disease 2019 , caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a pandemic that poses a major threat to global public health. As of July 3, 2020, there have been 10,871,361 confirmed cases of COVID-19 across 188 countries with 521,298 deaths [1] . Although the majority of patients with COVID-19 exhibit mild or moderate symptoms, 19% of patients develop severe symptoms or critical illness [2] . Yang et al. have reported the 28-day rate of mortality of critically ill patients with COVID-19 to be 61.5% [3] . Some COVID-19 patients experience mild symptoms in the early stages of disease and deteriorate over time. Without timely intervention and treatment, such cases of COVID-19 are associated with poor prognosis and high mortality [4] . The treatment of severe COVID-19 patients has become a major challenge for the prevention and control of COVID-19. Thus, it is imperative to identify reliable predictors of COVID-19 severity and enable treatment in the early stages of disease along with effectively allocating critical-care resources. Multiple studies have investigated the predictors of severe COVID-19, such as C-reactive protein (CRP), interleukin 6 (IL-6), and lymphocyte (LYM) counts [5] [6] [7] . However, the role of combinations of inflammatory markers in determining disease severity remains to be understood. Severe or critically ill COVID-19 patients exhibit extreme systemic inflammation and poor nutritional status [8, 9] . Serological biomarkers, including neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), lymphocyte-monocyte ratio (LMR), derived neutrophil-lymphocyte ratio (dNLR), high sensitivity C-reactive proteinalbumin ratio (HsCAR), albumin-to-fibrinogen ratio (AFR), prognostic nutritional index (PNI), systemic immune-inflammation index (SII), and high sensitivity Creactive protein-prealbumin ratio (HsCPAR), are indicators of systematic inflammation and nutritional status and function as prognostic factors for malignancies and inflammatory disease [11] [12] [13] . However, how these serological biomarkers change in the peripheral blood and their clinical values in COVID-19 remain unclear. In this study, we have investigated the potential of these serological biomarkers in predicting the severity of COVID-19. We enrolled 114 COVID-19 patients admitted to the Jinyintan Hospital in Wuhan between February 10 and March 7, 2020 in this study. All the patients were diagnosed based on the recommendations by the World Health Organization. The primary outcome was the development of severe COVID-19 during hospitalization. Mild to moderate or severe-critically ill cases of COVID-19 were diagnosed according to the Guidance for Corona Virus Disease 2019 (7 th edition) by the National Health Commission of China [14] . Of these 114 cases, 58 and 56 patients were severe (including 5 critically ill patients) and mild to moderate cases, respectively. This study was approved by the Jinyintan Hospital Ethics Committee and complied with the Declaration of Helsinki (approval no. KY-2020-79.01). The data used in this study were anonymous, thereby waiving the requirement for informed consent. We collected the information and analyzed parameters from patients, such as gender, age, comorbidities, and duration between hospital admission and discharge. Results of laboratory tests, such as hematological and coagulation indicators, biochemical indices, and inflammatory markers, were also collected and evaluated upon admission. The haematological tests including white blood cells (WBC, ×10 9 /L; normal range 4-10), platelet (PLT, ×10 9 /L; normal range 125-350), neutrophils (NEU, Table 2 . Adults with severe COVID-19 were classified based on the following conditions: (1) respiratory distress, respiration rate (RR) ≥ 30 times/minute; (2) resting state with oxygen saturation≤93%; (3) arterial blood oxygen partial pressure (PaO 2 )/oxygen concentration (FiO 2 ) ≤ 300 mm Hg; and (4) lung imaging showed significant lesion progression>50% within 24-48 hours. Patients were considered critically ill if any of the following criteria were met: (1) respiratory failure requiring mechanical ventilation; (2) shock; and (3) a combination of organ failure and ICU monitoring. Previous studies showed severe COVID-19 patients were more likely to have higher levels of neutrophils, high sensitivity C-reactive protein, fibrinogen and monocytes, and lower levels of lymphocytes, platelet, albumin and prealbumin. The new serological biomarkers listed in Table 1 were derived from a combination of two or more of the above indicators, including NLR, PLR, LMR, dNLR, HsCAR, AFR, PNI, SII, and HsCPAR. Table 1 lists the formulas used to calculate these indices. PLT counts(10 9 )*NEU counts(10 9 )/LYM counts(10 9 ) HsCRP(mg/L)/PA (g/L) respectively. Categorical variables were compared using the χ 2 test. Correlation analysis was performed using the Spearman method. The independent factors of severe COVID-19 were selected by univariate and multivariate logistic regression analyses. The relative risk was assessed using ninety-five percent confidence intervals (95% CI) of odds ratio(OR). We used the R Project for Statistical Computing to generate receiver operating characteristic (ROC) curves, nomogram, and calibration and decision curves, and calculate Harrell's concordance index (C-index). The predictive nomogram was a statistical model useful for risk assessment of severe COVID-19 and was developed using the selected independent factors. The discrimination and predictive abilities of the nomogram were assessed with C-index, where a larger index reflected a more accurate prediction of severe COVID-19. Calibration and decision curves were also generated to assess the predictive accuracy and agreement between predicted and observed severity and to assess the clinical usefulness of this nomogram respectively. p<0.05 were considered statistically significant (*p<0.05, **p<0.01, and ***p<0.001). Based on the progression of COVID-19 during hospitalization, the 114 confirmed patients were categorized into the mild to moderate (56 cases) and severe (58 cases) groups. Patients enrolled in severe group were those deteriorated from not severe to severe COVID-19 during hospitalization, and those who did not progress to severe illness until discharge were sorted into the mild to moderate group. Patients in severe group should met the criteria in section 2. Fig. 1i ). Since the serological indicators showed preference for patient groups, we wanted to verify if these indicators could serve as independent risk factors for severe COVID-19. Thus, we determined the crude Odds ratios (ORs) using univariate logistic regression analysis and adjusted the ORs for age and gender based on logistic regression analysis. HsCAR, dNLR, SII, and HsCPAR positively correlated with developing severe COVID-19, whereas PNI negatively correlated with the risk of developing severe disease (Fig. 2) To determine the potential of the serological indicators in predicting the severity of COVID-19, we generated ROC curves for each of the nine serological indicators. We also determined the area under ROC curve (AUC), sensitivity, specificity, positive and negative predictive values, true and false positive rates, true and false negative rates, accuracy, precision, and Youden index. C-reactive protein-albumin ratio; PNI, prognostic nutritional index; HsCPAR, high sensitivity C-reactive protein-prealbumin ratio. Based on the univariate and multivariate logistic regression analyses and performance of the ROC curves, HsCAR, HsCPAR, and PNI were used to generate the nomogram (Fig. 4a) . Each variable was assigned a score, and the total score was computed by summing individual scores, reflecting the probabilities of severe illness. Harrell's C-index for the prediction nomogram was 0.873 (95% CI: 0.808-0.938), suggesting the potential of the model to predict disease severity. The calibration (Fig. 4b ) and decision curves (Fig. 4c ) also demonstrated that the nomogram was capable of predicting severe disease in patients with COVID-19. Decision curve analysis of the nomogram to predict severe illness. Abbreviations: HsCAR, high sensitivity C-reactive protein-albumin ratio; PNI, prognostic nutritional index; HsCPAR, high sensitivity C-reactive protein-prealbumin ratio. Finally, we determined the correlation between the serological markers and duration of hospital stay using Spearman's rank correlation coefficient. NLR, LMR, HsCAR, PNI, AFR, and HsCPAR positively correlated with the length of hospital stay for COVID-19 patients (Fig. 4) . However, there was no correlation between PLR, dNLR, and SII, and duration of hospital stay. We adjusted the variables for age and gender using univariate linear regression analysis. HsCAR (β=0.346, p<0.0001), PNI (β=-0.195, p=0.040), and HsCPAR (β=0.246, p=0.011) correlated with duration of hospital stay. Subsequently, the three independent predictors were included as a part of the multivariate linear regression analysis to conclude that HsCAR (β=0.302, p=0.003) and HsCPAR (β=0.197, p=0.038) were independently associated with duration of hospital stay, whereas PNI was not. LMR, lymphocyte-monocyte ratio; HsCAR, high sensitivity C-reactive protein-albumin ratio; PNI, prognostic nutritional index; AFR, albumin-to-fibrinogen ratio; HsCPAR, high sensitivity C-reactive protein-prealbumin ratio. Despite global efforts to contain the COVID-19 outbreak since December 2019, single-day confirmed cases have been on the rise [21] . Moreover, there is no specific drug or vaccine currently available for COVID-19. The progression to severe illness results in high rates of mortality (40%) in patients [22] . A total of 114 patients diagnosed with COVID-19 were included in this study. Among these, 58 cases developed severe illness during hospitalization, while the remaining 56 patients exhibited mild to moderate disease until discharge from the hospital. We found that patients who developed severe illness during hospitalization had lower levels of LYM, ALB, PA, and HDL-C, consistent with previous studies [26] [27] [28] . Decreased ALB, PA, and HDL-C suggested the inhibition of protein synthesis in the liver that strongly correlated with the severity and poor prognosis of COVID-19 [28] . Virus-induced inflammation and immune response and nutritional status of the host play critical roles in disease progression [29, 30] . In this study, we observed Several studies have focused on the risk factors associated with severe illness in patients with COVID-19 [36] [37] [38] [39] . However, very few studies have comprehensively investigated the potential of these novel factors related to inflammation or nutrition in patients with COVID-19, and even fewer studies have used nomograms to determine their potential in predicting severe illness on admission. Liu et al. [40] constructed a nomogram using NLR and CRP with a C-index of 0.784, which was lower than that for the model in this study. Although Zhou et al. [41] established a model with a relatively high C-index of 0.863, it was based on clinical data from patients that requires detailed history and testing, and the data collected may not be objective. However, HsCAR and HsCPAR were also demonstrated to be the best objective indicators for predicting the occurrence of severe COVID-19 and duration of hospital stay for patients in our study. Moreover, although 366 COVID-19 patients were enrolled in Zhou's study, the percentage of severe COVID-19 patient was only 11.75% (43/323). And severe patients were older than non-severe patients. These factors may affect the accuracy of the model. Because our hospital was the designated hospital to treat COVID-19 patients in Wuhan at the beginning of the outbreak, the ratio of severe COVID-19 was relatively higher than other areas. Viral load and treatment options also determine the duration of hospital stay and severity of disease in a patient [39, [42] [43] [44] . Unfortunately, these data were not available for this study. Notably, this study has some limitations. First, the relatively small patient cohort may have influenced the statistical significance of the data in this study. Second, we did not analyze the correlation between the inflammatory makers and viral loads. Third, this study was based on the duration of hospital stay, not the time elapsed between onset of symptoms to discharge from the hospital. The required data is difficult to obtain if patients do not visit the hospital once they notice symptoms. The authors declared that there is no conflict of interest. Coronavirus 2019-nCoV, CSSE. Coronavirus 2019-nCoV Global Cases by Johns Hopkins CSSE Characteristics of and Important Lessons From the COVID-19 Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study COVID-19: a novel coronavirus and a novel challenge for critical care Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors The peripheral lymphocyte count as a predictor of severe COVID-19 and the effect of treatment with ciclesonide Eicosanoids: the Overlooked Storm in COVID-19 Evaluation of Nutritional Risk and its Association With Mortality Risk in Severe and Critically Ill COVID-19 Patients Could nutritional and functional status serve as prognostic factors for COVID-19 in the elderly Med Hypotheses The Research Progress on the Prognostic Value of the Common Hematological Parameters in Peripheral Venous Blood in Breast Cancer Systemic immune-inflammation index for predicting prognosis of colorectal cancer Albumin-to-Fibrinogen Ratio Independently Predicts 28-Day Mortality in Patients with Peritonitis-Induced Sepsis The General Office of the National Health Commission, The Office of the State Administration of Traditional Chinese Medicine Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients Clinical characteristics and risk factors of patients with severe COVID-19 in Jiangsu province, China: a retrospective multicentre cohort study Prealbumin as a Predictor of Prognosis in Patients With Coronavirus Disease Serum prealbumin values predict the severity of coronavirus disease 2019 (COVID-19) Is Albumin Predictor of Mortality in COVID-19? COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review Current epidemiological and clinical features of COVID-19; a global perspective from China Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu Epidemiology and clinical course of COVID-19 in Shanghai Correlation between the variables collected at admission and progression to severe cases during hospitalization among patients with COVID-19 in Chongqing Simple nomogram based on initial laboratory data for predicting the probability of ICU transfer of COVID-19 patients: Multicenter retrospective study Decreased serum albumin level indicates poor prognosis of COVID-19 patients: hepatic injury analysis from 2,623 hospitalized cases Host nutritional status and its effect on a viral pathogen COVID-19: consider cytokine storm syndromes and immunosuppression Is Albumin Predictor of Mortality in COVID-19 Laboratory Findings in SARS-CoV-2 Infections in Zigong, China: Key Points for Serum Prealbumin Coagulopathy and Vascular Disease in Covid-19 The Predictive Value of Preoperative High-Sensitive C-Reactive Protein/Albumin Ratio in Systemic Inflammatory Response Syndrome After Percutaneous Nephrolithotomy Pretreatment prognostic nutritional index as a prognostic factor in lung cancer: Review and meta-analysis Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan Risk factors for severe cases of COVID-19: a retrospective cohort study Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study Risk factors associated with disease severity and length of hospital stay in COVID-19 patients Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage Development and validation a nomogram for predicting the risk of severe COVID-19: A multi-center study in Sichuan ASSOCIATION OF INITIAL VIRAL LOAD IN SARS-CoV-2 PATIENTS WITH OUTCOME AND SYMPTOMS Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China Impact of SARS-CoV-2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients with Coronavirus Disease Guohui Xue: Conceptualization, Methodology, Formal analysis, Validation, Visualization, Writing -original draft. Xing Gan: Investigation, Resources, Software, Writing -Review & Editing. Zhiqiang Wu: Visualization, Resources Visualization, Software. Lin Hua: Visualization. Bing Zhou: Validation. Jie Xiang: Writing -review & editing, Resources, Conceptualization Junming Li: Conceptualization, Project administration, Funding acquisition, Writingreview & editing  Patients with coronavirus disease 2019 (COVID-19) had altered inflammatory markers  High sensitivity C-reactive protein-(pre)albumin ratios positively correlated with severe COVID-19  Prognostic nutritional index negatively correlated with risk of severe COVID-  Nomogram combining the three factors reliably predicted the progression of COVID-19  High sensitivity C-reactive protein-prealbumin and -albumin ratios helped estimate duration of hospitalization